HALO

After a 27% Plunge, Is Halozyme a Bad News Buy?

moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click here to view […]

Halozyme tumbles after company pauses study

moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click here to view […]

Why Halozyme (HALO) Stock Is Plunging Today

moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click here to view […]

Halozyme Announces Temporary Halt Of Phase 2 Trial Enrollment And Dosing For PEGPH20

[PR Newswire] – SAN DIEGO, April 4, 2014 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that as a result of a recommendation received yesterday from an independent Data Monitoring Committee … moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click here to view […]

8:02 am Halozyme announces Roche (RHHBY) marketing authorization for MabThera SC for patients with common forms of non-Hodgkin lymphoma in European Union

moreView todays social media effects on HALOView the latest stocks trending across Twitter. Click to view dashboardSee who Halozyme is hiring next, click here to view […]